These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 28642464)

  • 1. Serum C3 and Renal Outcome in Patients with Primary Focal Segmental Glomerulosclerosis.
    Liu J; Xie J; Zhang X; Tong J; Hao X; Ren H; Wang W; Chen N
    Sci Rep; 2017 Jun; 7(1):4095. PubMed ID: 28642464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Significance of IgM and C3 Glomerular Deposition in Primary Focal Segmental Glomerulosclerosis.
    Zhang YM; Gu QH; Huang J; Qu Z; Wang X; Meng LQ; Wang F; Liu G; Cui Z; Zhao MH
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1582-1589. PubMed ID: 27340287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-Deposition of IgM and C3 May Indicate Unfavorable Renal Outcomes in Adult Patients with Primary Focal Segmental Glomerulosclerosis.
    Mirioglu S; Caliskan Y; Ozluk Y; Dirim AB; Istemihan Z; Akyildiz A; Yazici H; Turkmen A; Kilicaslan I; Sever MS
    Kidney Blood Press Res; 2019; 44(5):961-972. PubMed ID: 31437846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal segmental glomerulosclerosis, excluding atypical lesion, is a predictor of renal outcome in patients with membranous nephropathy: a retrospective analysis of 716 cases.
    He HG; Wu CQ; Ye K; Zeng C; Huang YY; Luo SW; Yin W; Ye QR; Peng XM
    BMC Nephrol; 2019 Aug; 20(1):328. PubMed ID: 31438882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation, treatment and outcome of focal segmental glomerulosclerosis in Far North Queensland Australian adults.
    Greenwood AM; Gunnarsson R; Neuen BL; Oliver K; Green SJ; Baer RA
    Nephrology (Carlton); 2017 Jul; 22(7):520-530. PubMed ID: 27170059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Favorable prognostic significance of raised serum C3 concentration in patients with idiopathic focal glomerulosclerosis.
    Cosio FG; Hernandez RA
    Clin Nephrol; 1996 Mar; 45(3):146-52. PubMed ID: 8706354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of treatment failure and end-stage renal disease in familial focal segmental glomerular sclerosis.
    Hao X; Xie J; Ma J; Wang Z; Zhou Q; Yang L; Pan X; Ren H; Chen N
    Contrib Nephrol; 2013; 181():101-8. PubMed ID: 23689572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental Glomerulosclerosis.
    Troost JP; Trachtman H; Nachman PH; Kretzler M; Spino C; Komers R; Tuller S; Perumal K; Massengill SF; Kamil ES; Oh G; Selewski DT; Gipson P; Gipson DS
    Clin J Am Soc Nephrol; 2018 Mar; 13(3):414-421. PubMed ID: 29167190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary focal segmental glomerulosclerosis in nephrotic patients: common complications and risk factors.
    Zhang Q; Zeng C; Cheng Z; Xie K; Zhang J; Liu Z
    J Nephrol; 2012; 25(5):679-88. PubMed ID: 22009935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies.
    El Karoui K; Hill GS; Karras A; Moulonguet L; Caudwell V; Loupy A; Bruneval P; Jacquot C; Nochy D
    Kidney Int; 2011 Mar; 79(6):643-654. PubMed ID: 21178978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
    Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
    J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy.
    Kim SJ; Koo HM; Lim BJ; Oh HJ; Yoo DE; Shin DH; Lee MJ; Doh FM; Park JT; Yoo TH; Kang SW; Choi KH; Jeong HJ; Han SH
    PLoS One; 2012; 7(7):e40495. PubMed ID: 22792353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal segmental glomerulosclerosis in mild IgA nephropathy: a clinical-pathologic study.
    Weber CL; Rose CL; Magil AB
    Nephrol Dial Transplant; 2009 Feb; 24(2):483-8. PubMed ID: 18786972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgM as a novel predictor of disease progression in secondary focal segmental glomerulosclerosis.
    Pačić A; Šenjug P; Bacalja J; Tišljar M; Horvatić I; Bulimbašić S; Knotek M; Galešić K; Galešić Ljubanović D
    Croat Med J; 2017 Aug; 58(4):281-291. PubMed ID: 28857521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histomorphological classification of focal segmental glomerulosclerosis: a critical evaluation of clinical, histologic and morphometric features.
    Das P; Sharma A; Gupta R; Agarwal SK; Bagga A; Dinda AK
    Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):1008-16. PubMed ID: 22982914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
    Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
    Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: a cohort study of 348 cases with a mean 5-year follow-up.
    Cheng GY; Liu DW; Zhang N; Tang L; Zhao ZZ; Liu ZS
    Clin Nephrol; 2013 Jul; 80(1):40-6. PubMed ID: 23391320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
    Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.